Daridorexant for Adults with ADHD and Insomnia Disorder: An Exploratory Study
This naturalistic one-month study examined daridorexant 50 mg nightly in 24 adults with comorbid ADHD and insomnia, finding significant improvements in sleep quality (ISI/SCI scores), sleep efficiency via actigraphy, and sustained attention on cognitive testing. Secondary improvements were noted in ADHD symptoms and mood, with 62.5% achieving clinically meaningful insomnia improvement.
Sources
- MED — Sun Apr 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Read full article (translated)
- MED — Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Read full article (translated)
- MED — Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Read full article (translated)
Afișăm titlu + rezumat scurt în limita dreptului de autor; textul integral e la sursă.